What are some key supply considerations that sponsors need to keep in mind when planning a DCT? What should they look out for when choosing a supply partner?
Worth $14 million, entails providing project management and administrative oversight as the IRB of record for Biorepository Protocol and NIAID studies.
Margrethe Sørgaard offers 25 years’ experience in leading positions in clinical development and operation, medical affairs and drug safety/pharmacovigilance.
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.